Research Takeaway: An integrative approach to supporting immune checkpoint inhibitor treatment
A 2024 review examined the research for practical applications of integrative oncology strategies to support immune checkpoint inhibitor (ICI) treatment of solid tumors.
. First published on : Mar 17 2025Research Takeaway: I received heart-damaging treatment. How often do I need an echocardiogram?
Recent research underscores the importance of monitoring heart health before and after chemotherapy, especially for patients undergoing heart-damaging (cardiotoxic) treatments such as anthracyclines or trastuzumab. A 2025 study followed over 800 breast cancer survivors for an average of eight years. The researchers found that cardiac dysfunction increased over time, from 1.8% at two years after treatment to 15.3% at 15 years.
. Last modified on : May 12 2025Repurposed Drugs in Cancer Care
With widespread access to cancer research studies and anecdotal stories through internet searches and social media, people with cancer are becoming increasingly proactive in exploring all available treatment options. This trend has spurred grassroots adoption of complex supplement regimens and repurposed drug protocols. The fact that there is some evidence for various repurposed drugs to improve cancer outcomes makes it tempting for individuals to assume these drugs will help their cancer.
. First published on : Jan 28 2025Fenbendazole and Cancer: A Closer Look at Its Use and Risks
CancerChoices reviews and synthesizes the evidence behind complementary therapies including repurposed drugs. Given the significant interest in our review of Mebendazole and Fenbendazole, and our accompanying article on repurposed drugs, we’ve partnered with Mark Taylor of Patient Led Oncology to provide a deeper analysis of Fenbendazole.
. Last modified on : May 30 2025CancerChoices Supplement and Therapies Database: Top-Rated on Quality and Trustworthiness
We received the highest rating among the sites evaluated for quality and trustworthiness of information on cancer complementary therapies.
. Last modified on : Dec 02 2024Vitamin D: Hit the Sweet Spot to Reduce Cancer Risk
Evidence so far shows a lower risk of many types of cancer among people with mid-range blood vitamin D levels compared to low levels. However, if your blood level is already in the middle range, taking vitamin D supplements might not bring much benefit regarding cancer risk.
. Last modified on : Dec 27 2023SIO & ASCO Collaborate on Clinical Practice Guidelines
The collaboration represents the deepening fusion of conventional and integrative oncology.
. Last modified on : Dec 27 2023Maturing with Time and Evidence: The Updated American Cancer Society Lifestyle Guidelines
Most of all, they stress how important it is to adopt healthy patterns of eating and moving.
. Last modified on : Dec 27 2023BCCT/CancerChoices Take: MEAL Study: Effect of Eating Vegetables on Prostate Cancer Progression
Consider an integrative approach to reduce the risk that your cancer will progress.
. Last modified on : Dec 27 2023CancerChoices and BCCT Take: Cannabis and Head and Neck Cancer
If you have HPV-positive head and neck cancer, it would make sense to stop using cannabis.
. Last modified on : Dec 27 2023